Industry Could Help Asia Establish Adverse Event Monitoring Systems – DIA Conference
This article was originally published in PharmAsia News
Executive Summary
As countries like India and China reform their pharmacovigilance systems, opportunities are increasing for improved relationships between international companies and regulatory authorities despite stagnant harmonization efforts